UPDATE 2-Adamis shares slump as FDA declines to approve opioid overdose treatment
November 25, 2019 at 09:55 AM EST
Adamis Pharmaceuticals Corp said on Monday the U.S. Food and Drug Administration declined to approve its opioid overdose treatment, Zimhi, sending its shares plunging 56%.